Pulse Biosciences, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulse Biosciences, Inc. on May 16, 2019. The report details the results of the Company's Annual Meeting of Stockholders held on the same date at its headquarters in Hayward, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
The stockholders voted on two primary proposals:
- Election of Directors: Seven nominees were elected to serve until the 2020 annual meeting. All nominees received substantial majority support, with "For" votes ranging from approximately 7.55 million to 7.92 million. "Against" votes were minimal, ranging from 3,026 to 369,395.
- Ratification of Auditors: Stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019. The proposal received 19,290,028 votes "For" and 354 votes "Against."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the full list of elected directors and their tenure terms.
- Confirm the appointment of Deloitte & Touche LLP as the auditor for the 2019 fiscal year.
- Review the Company's most recent 10-K or 10-Q filings for financial performance data not included in this 8-K.